ACUTE LEUKEMIAS XVIII
Biology and Treatment Strategies

Munich, Germany - February 21-24, 2021

International Symposium

CORPORATE SUPPORT

The support of ACUTE LEUKEMIAS XVII by the following companies is gratefully acknowledged:

 

Gold Circle Corporate Members (Satellite Symposia):

Abbvie Deutschland GmbH
SAT II: Sunday, Feb 24, 2019
€ 25.000

 

 

AMGEN GmbH
SAT I: Sunday, Feb 24, 2019
€ 25.000

 

Astellas Pharma
SAT VI: Tuesday, Feb 26, 2019
€ 25.000

 

 

Celgene GmbH
SAT VII: Tuesday, Feb 26, 2019
€ 25.000

Daiichi Sankyo GmbH
SAT IV: Monday, Feb 25, 2019
€ 25.000

Jazz Pharmaceuticals Germany GmbH
SAT III: Monday, Feb 25, 2019
€ 22.000

Pfizer GmbH
SAT VIII: Tuesday, Feb 26, 2019
€ 25.000

 

Roche Pharma GmbH
SAT V: Monday, Feb 25, 2019
€ 25.000

 

 

Silver Circle Corporate Members (MTP Session):

Gilead Sciences GmbH
MTP: Monday, Feb 25, 2019
€ 15.000

      

 Bronze Circle Corporate Members (Industrial Exhibition):

Abbvie Deutschland GmbH
€ 4.500

 

 

AMGEN GmbH
€ 3.600

Daiichi Sankyo GmbH
€ 7.880

Helsinn Healthcare
€ 3.500

 

 

HISS Diagnostics GmbH
€ 2.400

Jazz Pharmaceuticals Germany GmbH
€ 3.940

 

Lipomed GmbH
€ 2.400

Neovii Biotech GmbH
€ 2.400
Novartis Pharma GmbH
€ 3.500

Pfizer GmbH
€ 2.400

   

 Roche Pharma GmbH
€ 5.060

 

Servier Deutschland GmbH
€ 6.750

TEVA GmbH
€ 6.000

Vector Therapeutics
€ 6.750

 

Other Corporate Support:

AGIOS
Sponsors Poster Prizes
€ 1.000
AGIOS
Advertisement Annals of Hematology
€ 1.500

 

AMGEN GmbH
Symposium APP
€ 5.000

Gilead Sciences GmbH
Support AGIHO Symposium
€ 5.000
Helsinn Healthcare
Advertisement Annals of Hematology
€ 1.500

   

German Research Sponsors: 

HelmholtzZentrum München

€ 5.000

ELN Foundation
€ 1.000